Feasibility of using Making Mindfulness Matter© for children with epilepsy and their parents: A pilot randomized controlled trial.

Epilepsy BehavOct 1, 2026 (epub)
Clinical ResearchNeurologyPediatrics

Karina N Tassiopoulos, Karen Bax, Klajdi Puka et al.

✦ AI-curated · Sources linked

In 30 seconds

This parallel, 1:1 pilot randomized controlled trial assessed whether an eight-week, live-online family mindfulness program could be delivered to children with epilepsy aged 4–10 years and their parents in Ontario, Canada. Families were assigned to Making Mindfulness Matter or a waitlist control, with feasibility evaluated through participation, attendance, delivery fidelity, adherence, and satisfaction. Of 298 dyads screened, 72 were randomized, a participation rate of 31%. The program was delivered with 80-100% of curriculum units completed; most families attended more than 75% of sessions and reported engagement and satisfaction.

Key findings

  • Of 298 screened dyads, 72 were randomized; the participation rate was 31%.
  • Session fidelity was high, with 80-100% of curriculum delivered.
  • Most families attended more than 75% of sessions, practiced skills weekly, and were satisfied with the program.
  • Time commitment was identified as a key barrier to recruitment and retention.

Why it matters

Children with epilepsy may face health-related quality-of-life challenges, and family context can shape coping. This trial suggests a community-based online mindfulness program can be delivered as intended and is acceptable to participating families. The feasibility findings provide a basis for further evaluation, while the recruitment and retention barrier highlights the practical importance of fitting family programs into participants’ schedules.

What to keep in mind

This was a pilot feasibility trial, and only 31% of screened dyads participated; time commitment also hindered recruitment and retention. The abstract does not report comparative clinical outcomes.

Source

Published in Epilepsy Behav. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Neurology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.